A Sanger sequencing protocol for SARS‐CoV‐2 S‐gene

We describe a Sanger sequencing protocol for SARS‐CoV‐2 S‐gene the Spike (S)‐glycoprotein product of which, composed of receptor‐binding (S1) and membrane fusion (S2) segments, is the target of vaccines used to combat COVID‐19. The protocol can be used in laboratories with basic Sanger sequencing ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniels, Rodney S., Harvey, Ruth, Ermetal, Burcu, Xiang, Zheng, Galiano, Monica, Adams, Lorin, McCauley, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447197/
https://www.ncbi.nlm.nih.gov/pubmed/34346163
http://dx.doi.org/10.1111/irv.12892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447197/
https://www.ncbi.nlm.nih.gov/pubmed/34346163
http://dx.doi.org/10.1111/irv.12892

Ejemplares similares